<?xml version="1.0"?>
<notificationOfRemoval>

    <schemaVersion>X0203</schemaVersion>

    <exchange>
        <cik>0001143313</cik>
        <entityName>NYSE MKT LLC</entityName>
    </exchange>

    <issuer>
        <cik>315545</cik>
        <entityName>PROVECTUS BIOPHARMACEUTICALS, INC.</entityName>
        <fileNumber>001-36457</fileNumber>
        <address>
            <street1>7327 Oak Ridge Highway Suite A</street1>
            <street2></street2>
            <city>Knoxville</city>
            <stateOrCountryCode>TN</stateOrCountryCode>
            <stateOrCountry>TENNESSEE</stateOrCountry>
            <zipCode>37931</zipCode>
        </address>
        <telephoneNumber>866-594-5999</telephoneNumber>
    </issuer>

    <descriptionClassSecurity>Warrants exercisable for one share of common stock par value $0.001 per share at an exercise price of $0.85 per share (Expiring August 30, 2021.)</descriptionClassSecurity>

    <ruleProvision>17 CFR 240.12d2-2(b)</ruleProvision>

    <signatureData>
        <signatureName>Benjamin Sawyer</signatureName>
        <signatureTitle>Manager</signatureTitle>
        <signatureDate>2017-04-21</signatureDate>
    </signatureData>
</notificationOfRemoval>
